Q3/25 Sales and EBITDA beat estimates. The Altero stake sale boosted an already strong cash flow and we see additional value from associated companies. We reiterate our dividend forecast but see substantial upside if rewarding shareholders is prioritized.
Substantial dividend upside Read More »


